Effect of Statin mixed toothpaste on patients with gum disease

Effect of 2% Atorvastatin medicated dentifrice on patients with chronic periodontitis - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067422

Enrollment

Registered

2024-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M272- Inflammatory conditions of jaws

Interventions

Intervention1: 2% Atorvastatin medicated dentifrice: 2% Atorvastatin medicated dentifrice is prescribed to the patients Dose: 0.5ml of toothpaste Frequency: Twice daily Duration: 3 months Control Int

Eligibility

Inclusion criteria

Inclusion criteria: Systemically healthy individuals Periodontitis patients with probing pocket depths more than 4 mm

Exclusion criteria

Exclusion criteria: Individuals with any form of systemic illness Individuals under any systemic medications Individuals receiving antibiotic therapy or nonsteroidal anti inflammatory drugs during the previous two months periodontal treatment during the previous 6 months Use of oral topical agents like mouthwash, gum paints before 3 months and during the study Smokers Pregnancy lactation

Design outcomes

Primary

Measure	Time frame
To access the efficacy of with 2% Atorvastatin medicated dentifrice on chronic periodontitis. Timepoint: Baseline, 6 months	—

Secondary

Measure	Time frame
To Co-relate the effect of 2% Atorvastatin with clinical parameters: Bleeding on probing Probing Depth Clinical Attachment level Gingival Index Timepoint: Baseline, 6 months	—

Countries

India

Contacts

Public ContactDr. Pranavi J

KARPAGA VINAYAGA INSTITUTE OF DENTAL SCIENCES

drlakshmiganth@gmail.com9940724656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026